Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helfand

Showing results (441-450 of 657) with videos related to

Pageof 66
Sort By:
Journal of Alzheimer'S Disease : JAD|June 19, 2023
Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 CarriersSmita Patel, Jun Wei, Zhuqing Shi, et al.
The Canadian Journal of Urology|April 16, 2022
How I do it: Aquablation in very large prostates (> 150 mL)Brian T Helfand, Ali Kasraeian, Steve Sterious, et al.
Clinical Lung Cancer|February 13, 2023
Association of Reported Candidate Monogenic Genes With Lung Cancer RiskAndrew S Rifkin, Ethan M Less, Jun Wei, et al.
European Urology|December 26, 2017
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8<sup>+</sup> T-cells Derived from Patients with Metastatic Castrate-resistant DiseaseQiang Zhang, Brian T Helfand, Benedito A Carneiro, et al.
The American Journal of Medicine|April 24, 2022
Sickle Cell Trait and Risk for Common Diseases: Evidence from the UK BiobankJoseph Hulsizer, W Kyle Resurreccion, Zhuqing Shi, et al.
The Prostate|June 21, 2018
Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk scoreBrian T Helfand, Haitao Chen, Richard J Fantus, et al.
Urology|March 30, 2019
A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) StudyBrian T Helfand, Victor P Andreev, Nazema Y Siddiqui, et al.
The Journal of Urology|April 21, 2009
Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trialBrian T Helfand, Anne K Mongiu, Claus G Roehrborn, et al.
Biochemistry|January 28, 2004
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structurePius S Padayatti, Marion S Helfand, Monica A Totir, et al.
Emerging Infectious Diseases|March 27, 2001
Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipientsA I Hussain, V Shanmugam, W M Switzer, et al.
Pageof 66

Showing results (441-450 of 657) with videos related to

Sort By:
Pageof 66
Journal of Alzheimer'S Disease : JAD|June 19, 2023
Refining Risk for Alzheimer's Disease Among Heterozygous APOEɛ4 CarriersSmita Patel, Jun Wei, Zhuqing Shi, et al.
The Canadian Journal of Urology|April 16, 2022
How I do it: Aquablation in very large prostates (> 150 mL)Brian T Helfand, Ali Kasraeian, Steve Sterious, et al.
Clinical Lung Cancer|February 13, 2023
Association of Reported Candidate Monogenic Genes With Lung Cancer RiskAndrew S Rifkin, Ethan M Less, Jun Wei, et al.
European Urology|December 26, 2017
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8<sup>+</sup> T-cells Derived from Patients with Metastatic Castrate-resistant DiseaseQiang Zhang, Brian T Helfand, Benedito A Carneiro, et al.
The American Journal of Medicine|April 24, 2022
Sickle Cell Trait and Risk for Common Diseases: Evidence from the UK BiobankJoseph Hulsizer, W Kyle Resurreccion, Zhuqing Shi, et al.
The Prostate|June 21, 2018
Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk scoreBrian T Helfand, Haitao Chen, Richard J Fantus, et al.
Urology|March 30, 2019
A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) StudyBrian T Helfand, Victor P Andreev, Nazema Y Siddiqui, et al.
The Journal of Urology|April 21, 2009
Variation in institutional review board responses to a standard protocol for a multicenter randomized, controlled surgical trialBrian T Helfand, Anne K Mongiu, Claus G Roehrborn, et al.
Biochemistry|January 28, 2004
Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structurePius S Padayatti, Marion S Helfand, Monica A Totir, et al.
Emerging Infectious Diseases|March 27, 2001
Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipientsA I Hussain, V Shanmugam, W M Switzer, et al.
Pageof 66